Publications - Gerardo Colon-Otero, M.D.
Back to Research Profile
- Palmieri FM, DePeri ER, Mincey BA, Smith JA, Wen LK, Chewar DM, Abaya R, Colon-Otero G, Perez EA. Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population. Mayo Clin Proc 2009 Apr; 84(4):317-22.
View PubMed
- Zubair AC, Grant R, Wu W, Tun H, Rivera C, Moreno-Aspitia A, Joyce M, Roy V, Colon-Otero G, Solberg LA. Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell disease patients. Transfusion 2008 Jun; 48(6):1106-14. Epub 2008 Feb 25.
View PubMed
- Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer 2008 Feb 1; 112(3):447-54.
View PubMed
- Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, Dunn AN. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis. Cancer 2008 Feb 1; 112(3):447-54.
View PubMed
- Moreno-Aspitia A, Colon-Otero G. Author reply. Cancer 2007 Mar 15; 109(6):1212.
View PubMed
- Moreno-Aspitia A, Colon-Otero G, Hoering A, Tefferi A, Niedringhaus RD, Vukov A, Li CY, Menke DM, Geyer SM, Alberts SR. Thalidomide therapy in adult patients with myelodysplastic syndrome - A North Central Cancer Treatment Group Phase II trial. Cancer 2006 Aug 15; 107(4):767-72.
View PubMed
- Moreno-Aspitia A, Colon-Otero G, Hoering A, Tefferi A, Niedringhaus RD, Vukov A, Li CY, Menke DM, Geyer SM, Alberts SR, North Central Cancer Treatment Group. Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial. Cancer 2006 Aug 15; 107(4):767-72.
View PubMed
- Young PM, Paz-Fumagalli R, Colon-Otero G, Sevin BU. Postoperative pseudoaneurysm after debulking surgery for ovarian cancer: Long-term success of percutaneous thrombin injection. J Gynecol Surg 2006; 22(2):77-80.
View PubMed
- Dispenzieri A, Moreno-Aspitia A, Suarez GA, Lacy MQ, Colon-Otero G, Tefferi A, Litzow MR, Roy V, Hogan WJ, Kyle RA, Gertz MA. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome: and a review of the literature. Blood 2004 Nov 15; 104(10):3400-7.
View PubMed
- Colon-Otero G, Davis TH, Elkins S, Kosty MP, Mudad R, Niell HB, Wozniak AJ. Oncology Board Review study guide. American Journal of Oncology Review 2004 Nov; 3(11 Suppl 10):1-20.
- Andrews TR, Colon-Otero G, Calamia KT, Menke DM, Boylan KB, Kyle RA. Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral neuropathy. Mayo Clin Proc 2002 Dec; 77(12):1287-90.
View PubMed
- Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood 2002 May 15; 99(10):3854-6.
View PubMed
- Kumar S, Menke DM, Dewald GW, Colon-Otero G. Agnogenic myeloid metaplasia associated with Klinefelter syndrome: a case report. Ann Hematol 2002 Apr; 81(4):215-8.
View PubMed
- Kuriakose P, Colon-Otero G, Paz-Fumagalli R. Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: A 5-year single-institution retrospective study. J Vasc Interv Radiol 2002 Feb; 13(2 Part 1):179-84.
View PubMed
- Colon-Otero G, Niedringhaus RD, Hillman SH, Geyer S, Sloan J, Krook JE, Windschitl HE, Marks RS, Wiesenfeld M, Tschetter LK, Jett JJ. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs - A north central cancer treatment group trial. Am J Clin Oncol-Cancer Clinical Trials 2001 Dec; 24(6):551-5.
View PubMed
- Menke DM, Griesser H, Moder KG, Tefferi A, Luthra HS, Cohen MD, Colon-Otero G, Lloyd RV. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol 2000 Feb; 113(2):212-8.
View PubMed
- Moreno A, Colon-Otero G, Solberg LA Jr. The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard? Oncologist 2000; 5(3):238-49.
View PubMed
- McLaughlin MP, Sevin BU, Colon-Otero G, Pettit PDM. Radiosensitizing approaches to patients with advanced cervical cancer. Cancer Research, Therapy & Control 2000; 10(4):279-285.
- Colon-Otero G, Moreno A, Tefferi A. A critical review of new treatments for the myelodysplastic syndromes. Cancer Research, Therapy & Control 1999; 9(3-4):281-88.
- O'Connell MJ, Nagorney DM, Bernath AM, Schroeder G, Fitzgibbons RJ, Mailliard JA, Burch P, Bolton JS, Colon-Otero G, Krook JE. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 1998 Jul; 16(7):2528-33.
View PubMed
- Colon-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Cancer J Sci Am 1997 Sep-Oct; 3(5):297-302.
View PubMed
- Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. J Clin Oncol 1995 Aug; 13(8):2012-5.
View PubMed
- Schild SE, Wharen RE Jr, Menke DM, Folger WN, Colon-Otero G. Primary lymphoma of the spinal cord. Mayo Clin Proc 1995 Mar; 70(3):256-60.
View PubMed
- Perniciaro C, Kuechle MK, Colon-Otero G, Raymond MG, Spear KL, Pittelkow MR. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc 1994 Sep; 69(9):851-5.
View PubMed
- Menke DM, Greipp PR, Colon-Otero G, Solberg LA Jr, Cockerill KJ, Hook CC, Witzig TE. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders. Arch Pathol Lab Med 1994 Aug; 118(8):811-4.
View PubMed
- Colon-Otero G, Malkasian GD, Edmonson JH. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer. J Natl Cancer Inst 1993 Nov 17; 85(22):1858-60.
View PubMed
- Edmonson JH, Hartmann LC, Long HJ, Colon-Otero G, Fitch TR, Jefferies JA, Braich TA, Maples WJ. Granulocyte-macrophage colony stimulating factor. Cancer 1992 Nov 15; 70:2529-2539.
View PubMed
- Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia: a myelodysplastic syndrome that mimics immune thrombocytopenic purpura. Am J Clin Pathol 1992 Nov; 98:502-10.
View PubMed
- Colon-Otero G, Menke D, Hook CC. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am 1992 May; 76(3):581-97.
View PubMed
- Silverstein MN, Petitt RM, Solberg LA Jr, Schacter LP, Rosenbloom B, Silver RT, et al. Anagrelide: a therapy for thrombocythemic states, experience in 577 patients. Am J Med 1992; 92:69-76.
View PubMed
- Colon-Otero G, Cockerill KJ, Bowie EJW. The diagnosis of bleeding disorders. Postgrad Med 1991 Sep; 90:145-150.
View PubMed
- Colon-Otero G, Sando JJ, Sims JL, McGrath E, Quesenberry PJ. Inhibition of hemopoietic growth factor-induced proliferation by ADP-ribosylation inhibitors. Blood 1987 Sep; 70:686-693.
View PubMed
- Colon-Otero G, Gilchrist GS, Holcomb GR, Ilstrup DM, Bowie EJ. Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc 1987 May; 62(5):379-85.
View PubMed
- Colon-Otero G, McClure SP, Phyliky RL, White WL, Banks PM. Peripheral T-cell lymphoma simulating Hodgkin's disease with initial bone marrow involvement. Mayo Clin Proc 1986 Jan; 61(1):68-71.
View PubMed
- Colon-Otero G, Li CY, Dewald GW, White WL. Erythrophagocytic acute lymphocytic leukemia with B-cell markers and with a 20q- chromosome abnormality. Mayo Clin Proc 1984 Oct; 59(10):678-82.
View PubMed
- Kempson SA, Colon-Otero G, Ou SY, Turner ST, Dousa TP. Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest 1981 May; 67(5):1347-60.
View PubMed
|